Stocks · Health care · Pharmaceutical Preparations

Aquestive Therapeutics, Inc.

AQST Clue Score18
United States Fiscal year ends December CIK 0001398733 Results filed 3 Nov 2026

What the insiders did Balanced

Insider
Date
Role
Action
Shares
Price
Amount
Cassie Jung
10 Mar 2026
Chief Operating Officer
Sell
45,791
$4.17
$191.09K
Sherry Korczynski
10 Mar 2026
Chief Commercial Officer
Sell
15,741
$4.17
$65.69K
A Ernest Toth Jr
10 Mar 2026
Chief Financial Officer
Sell
58,254
$4.17
$243.09K
Melina Cioffi
10 Mar 2026
SVP, Regulatory Affairs
Sell
25,311
$4.17
$105.62K
Lori J Braender
10 Mar 2026
Chief Legal Officer
Sell
40,102
$4.17
$167.35K
Daniel Barber
10 Mar 2026
President and CEO
Sell
180,677
$4.17
$753.97K
Peter E. Boyd
10 Mar 2026
Chief People Officer
Sell
29,814
$4.17
$124.41K
Cassie Jung
26 Nov 2024
Chief Operating Officer
Sell indirect
44
$4.87
$214.06
Alexander Mark Schobel
10 Feb 2021
Chief Innovation/Tech Officer
Sell
23,460
$6.75
$158.36K
Alexander Mark Schobel
9 Feb 2021
Chief Innovation/Tech Officer
Sell
11,540
$6.75
$77.90K
Alexander Mark Schobel
8 Feb 2021
Chief Innovation/Tech Officer
Sell
40,792
$6.50
$265.15K
John T. Maxwell
18 Aug 2020
SVP-Chief Financial Officer
Sell
3,000
$8.00
$24.00K
Keith J Kendall
4 Jun 2020
CEO and President
Sell
50,000
$5.11
$255.31K
Alexander Mark Schobel
8 May 2020
Chief Innovation/Tech Officer
Sell
40,000
$5.00
$200.00K
Alexander Mark Schobel
29 Apr 2020
Chief Innovation/Tech Officer
Sell
40,000
$4.50
$180.00K
Alexander Mark Schobel
27 Apr 2020
Chief Innovation/Tech Officer
Sell
40,000
$4.00
$160.00K
Alexander Mark Schobel
14 Apr 2020
Chief Innovation/Tech Officer
Sell
40,000
$3.70
$148.00K

What was left out

Form 4 filings counted 284
Amendments (4/A) skipped 8
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 4
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 11,746,136
Sales filed before the plan box existed 9
History held since 26 Jul 2018